CopyPastehas never been so tasty!

Oncology Therapeutics Market in India to 2018

by prbharatbook

  • 0
  • 0
  • 0
40 views

The Indian oncology therapeutics market for breast cancer, lung cancer, colorectal cancer, prostate cancer and NHL was estimated to be worth $153.3m in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 12.7% from 2004. It is expected to reach $238.8m in 2018 at a CAGR of 6.5% from 2011. The slower growth in the forecast period is mainly due to the reduction in the price of leading marketed products for breast cancer, colorectal cancer, lung cancer and NHL after all 348 drugs on the National List of Essential Medicines (NLEM) are brought under price control regulations.

The limitations of the current market are unclear patent laws, restrictive pricing and reimbursement policies, ailing infrastructure, and insufficient government aid. Low patient affordability is also a major restraint, and one that reimbursement and insurance policies must address if the market is to develop in the future.

Scope

- The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the breast cancer, colorectal cancer, prostate cancer, lung cancer and NHL markets.
- Data and analysis for the oncology therapeutics market in India
- Annualized market data for the oncology therapeutics market in India from 2004 to 2011, with forecasts to 2018
- Key drivers and restraints that have had a significant impact on the market
- The competitive landscape of the oncology therapeutics market in India
- Key M&A activities and licensing agreements that have taken place in the Indian oncology therapeutics market

Reasons to buy

The report will enhance your decision-making capability by allowing you to -
- Align your product portfolio to the markets with high growth potential
- Develop market-entry and market-expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
- Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the oncology market
- Develop key strategic initiatives by understanding the key focus areas and leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

Companies Mentioned

Dr. Reddy’s Laboratories
Natco Pharma
AstraZeneca
Cipla

Table of content :

1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 10
2 Oncology Therapeutics Market in India – Introduction 11
3 Oncology Therapeutics Market in India – Market Overview 12
3.1 Population Dynamics 12
3.2 Cancer Registration Background in India 13
3.3 Most Common Cancers in India 14
3.4 Cancer Mortality Rate 15
3.5 Market Characterization and Forecasts 16
3.6 Annual Cost of Therapy 18
3.7 Treatment Usage Pattern 19
3.7.1 Diseased Population 20
3.7.2 Prescription Population 20
3.8 Drivers and Barriers 21
3.8.1 Drivers 21
3.8.2 Restraints 22
4 Oncology Therapeutics Market in India – Therapeutic Landscape 24
4.1 Breast Cancer 24
4.1.1 Disease Overview 24
4.1.2 Staging 24
4.1.3 Market Size 26
4.1.4 Annual Cost of Therapy 28
4.1.5 Treatment Usage Pattern 29
4.1.6 Key Marketed Products 30
4.1.7 Competitive Landscape 31
4.2 Colorectal Cancer 32
4.2.1 Disease Overview 32
4.2.2 Staging 32
4.2.3 Market Size 34
4.2.4 Annual Cost of Therapy 35
4.2.5 Treatment Usage Pattern 36
4.2.6 Key Marketed Products 37
4.2.7 Competitive Landscape 38
4.3 Prostate Cancer 39
4.3.1 Disease Overview 39
4.3.2 Staging 39
4.3.3 Market Size 41
4.3.4 Annual Cost of Therapy 42
4.3.5 Treatment Usage Pattern 43
4.3.6 Key Marketed Products 44
4.3.7 Competitive Landscape 45
4.4 Lung Cancer 46
4.4.1 Disease Overview 46
4.4.2 Staging 46
4.4.3 Market Size 49
4.4.4 Annual Cost of Therapy 50
4.4.5 Treatment Usage Pattern 51
4.4.6 Key Marketed Products 52
4.4.7 Competitive Landscape 53
4.5 Non-Hodgkin’s Lymphoma 54
4.5.1 Disease Overview 54
4.5.2 Staging 54
4.5.3 Market Size 55
4.5.4 Annual Cost of Therapy 56
4.5.5 Treatment Usage Pattern 57
4.5.6 Key Marketed Products 58
4.5.7 Competitive Landscape 59
5 Oncology Therapeutics Market in India – Pipeline Analysis 60
5.1 Introduction 60
5.2 Breast Cancer 61
5.2.1 Introduction 61
5.3 Colorectal Cancer 64
5.3.1 Introduction 64
5.4 Prostate Cancer 66
5.4.1 Introduction 66
5.5 Lung Cancer 68
5.5.1 Introduction 68
5.6 Non-Hodgkin’s Lymphoma 71
5.6.1 Introduction 71
6 Oncology Therapeutics Market in India – Competitive Landscape 73
6.1 Market Share Analysis 73
6.2 Competitive Profiling 74
6.2.2 Dr. Reddy’s Laboratories 75
6.2.3 Natco Pharma 76
6.2.4 AstraZeneca 77
6.2.5 Cipla 78
7 Oncology Therapeutics Market in India – Strategic Consolidations 79
7.1 Introduction 79
7.2 Merger & Acquisition Deals 80
7.2.1 M&A by Year 80
7.3 Licensing Agreements 82
7.3.1 Deals by Year 82
7.3.2 Major Licensing Deals 82
7.4 Co-Development Deals 84
7.4.1 Deals by Year 84
7.4.2 Major Co-Development Deals 84
8 Oncology Therapeutics Market in India – Appendix 85
8.1 Market Definitions 85
8.2 Abbreviations 85
8.3 Bibliography 86
8.4 Research Methodology 86
8.4.1 Coverage 86
8.4.2 Secondary Research 87
8.4.3 Primary Research 87
8.4.4 Expert Panel Validation 88
8.5 Contact Us 88
8.6 Disclaimer 88

For more information, visit : http://www.bharatbook.com/healthcare-market-research-reports/oncology-therapeutics-market-in-india-to-2018-introduction-of-market-based-pricing-to-fuel-price-wars-and-intense-competition-among-domestic-and-multinational-players.html

Contact Us at:

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Call UK: +44 7405 208461
Toll Free No in USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
 Website: www.bharatbook.com 
 Follow us on twitter: https://twitter.com/researchbook 
 Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau 
 Our Blog : http://blog.bharatbook.com/ 

Add A Comment: